Innovation

Solutions: What Do Your Keystrokes Say About Parkinson’s?

Analyzing typing patterns may help diagnose the disease


By Christine Hall | December 5, 2017

By the time Parkinson’s disease is diagnosed, the damage is likely already done.

But what if there was a way to check for early signs of this progressive disorder of the nervous system? What if a smartphone app or computer keyboard could pick up Parkinson’s just from the way someone swiped or typed? What if it could determine how well people with Parkinson’s are responding to their medications?

Using a combination of digital health applications and artificial intelligence (AI), Luca Giancardo, Ph.D., and other scientists in the Center for Precision Health at The University of Texas Health Science Center at Houston (UTHealth) have created a program that can isolate differences in the typing signatures of people with and without Parkinson’s disease.

As the population ages, the number of people diagnosed with the disorder is expected to rise. Warning signs of Parkinson’s include rigidity or resting tremors, but with earlier intervention, doctors may be able to slow these symptoms.

Yet Giancardo, an assistant professor at UTHealth, said it’s not practical to test everyone for the onset of Parkinson’s, even if there was an easy way to do it. Rather, it is better to monitor an activity people are already doing regularly to see if there are any clues that could lead to a possible diagnosis of the disorder.

With that in mind, he developed a program that analyzes typing signatures—the keystroke patterns and quirks of individual users. The program can be downloaded onto a computer or smartphone and runs in the background while users go about their day, using their computers and smartphones as they normally would.

Giancardo calls this type of monitoring “passive monitoring,” to denote a test that doesn’t require any kind of special activity and can be done outside of the clinic. The goal, he said, is to find hidden patterns in the movements.

The average person takes 100 milliseconds to press and release a key, he said. Whenever a person types on a smartphone or desktop computer, the pressure and speed of the movements will generate a score that would quantify the patterns in the typing signatures.

“The measurements include the time from when you press a key until the time you release it,” he added.

Part of this work was possible through collaborations with faculty, clinicians and researchers at the Massachusetts Institute of Technology, HM CINAC and the Madrid-MIT M+Vision Consortium. Namely: Prof. Martha Gray, Prof. Jose Obeso, Teresa Arroyo Gallego, Dr. Alvaro Sanchez Ferro, Ian Butterworth, Michele Matarazzo, Paloma Montero and Veronica Puertas-Martin. The work was supported, in part, by the Michael J. Fox Foundation for Parkinson’s Research.

At the moment, Giancardo is testing the program to see how people with Parkinson’s disease are responding to their medications. Although the program is still in the research phase, results suggest that changes in the typing signature could indicate that a medication is not working.

“We’ve learned from some animal studies that if we could diagnose people seven to 15 years earlier, we could get them using drugs designed to slow the neuron degeneration,” Giancardo said.

Giancardo hopes one day to extend these AI techniques to other conditions, including Alzheimer’s, and to integrate them with imaging and other tools.

Mya Schiess, M.D., has been working with Giancardo for the past year and said this technology could be used to measure the mobility of individuals afflicted by Parkinson’s.

“We could profile their mobility and, once we get their measurement, show change over time or rate a disease that is progressive,” said Schiess, vice chair of neurology and the Adriana Blood Endowed Chair in Neurology at McGovern Medical School at UTHealth, and a member of the medical staff at Memorial Hermann-Texas Medical Center.

She is also working to get patients who have had deep brain stimulation to treat their Parkinson’s involved with Giancardo’s program.

A typing profile could show how a person might benefit from deep brain stimulation, which implants a stimulator—similar to a pacemaker—that sends electrical impulses to electrodes implanted in the brain. After this treatment, she said, researchers would be able to show improvement in some tasks and neuroplasticity.

“This is on the verge of becoming a very important investigative tool and biomarker,” Schiess said.




Social Posts

profile_image

MD Anderson Cancer Center

@MDAndersonNews

Earn #CME while discussing novel and multidisciplinary approaches for treating genitourinary cancers on Nov. 1-2. Experts include @aapariciomd, @SurenaMatinMD, @EfstathiouEleni, @nnavai, @ChadTangMD and @cgwoodMD.Learn more: https://t.co/iklv6ISIxh #endcancer

28 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

#VHAiEx is coming and you can watch every story, every innovation, every discovery LIVE! Join us for the kickoff right here on Oct. 22: https://t.co/C7kimBMAhf

44 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans are brewing up beer with pints that give back https://t.co/zyAMdwAUAs via @FoxBusiness

9 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“My sons wouldn’t be here if I didn’t come to MD Anderson,” says #lymphoma survivor Brian Heard: https://t.co/2TMtqzzpkB #lymsm #endcancer https://t.co/0NdB8ZbW47

9 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“Circulating tumor DNA is certainly in newly diagnosed, untreated metastatic patients is a very reliable and accurate, and rapid way to assess the genotyping of the patients,” says our @skopetz of #colorectalcancer treatment: https://t.co/J95RXtY787 #endcancer

10 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

#VHADiffusion is #ChangingLivesSavingLives and you can see exactly how live at #VHAiEx with successful innovators from across the country presenting their work. https://t.co/crrVTdE42o

11 hours ago
profile_image

UTHealth

@UTHealth

Preclinical research helps explain why fatty livers are more susceptible to cancer: https://t.co/pCHsQGgOVD

11 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Neil Hanchard talks about his work sequencing genomes from countries across Africa. https://t.co/A4hKregVX3 #ASHG19 #genomes

11 hours ago
profile_image

Houston Methodist

@MethodistHosp

Hear George Springer talk about the team behind the team. We're honored to take care of the @Astros.Let’s knock it out of the park tonight! ⚾ #TakeItBack https://t.co/opulRnD9s6

13 hours ago
profile_image

Memorial Hermann

@memorialhermann

@lexi_red We'd like to hear more about your experience. Please send your contact information and Memorial Hermann location to help@memorialhermann.org so we can look into this.

13 hours ago
profile_image

BCMHouston

@bcmhouston

RT @CHI_StLukes: Ready for Game 4 of the #ALCS? Experts from @bcmhouston and Baylor St. Luke’s share health tips to get you through the @as…

13 hours ago
profile_image

BCMHouston

@bcmhouston

RT @bcm_careerdev: Thanks to Dr. Melissa Sistrunk @NLawGlobal for serving as a job shadow host + exposing @bcmhouston students to #IPLaw c…

13 hours ago
profile_image

Memorial Hermann

@memorialhermann

Memorial Hermann Sports Park, a new sports medicine and human performance facility on the campus of Memorial Hermann Katy Hospital, opened this past weekend. Learn more: https://t.co/HouQEszaCU. #sports #sportsmedicine https://t.co/PFeyxV28wb

14 hours ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

Ready for Game 4 of the #ALCS? Experts from @bcmhouston and Baylor St. Luke’s share health tips to get you through the @astros playoff series. #HoustonAstros #TakeItBack @SeragHashem @isulapas @CBallantyneMD https://t.co/jjIXwSMRWO

14 hours ago
profile_image

UTHealth

@UTHealth

.@UTHealth welcomes new members to its Development Board: https://t.co/EId51KaDBF #ManyFacesOfUTHealth

14 hours ago